May 11, 2023
The US Food and Drug Administration (FDA) has approved pegunigalsidase alfa (Elfabrio, Chiesi Global Rare Diseases/Protalix BioTherapeutics), an enzyme replacement therapy (ERT) to treat adults with […]
May 11, 2023
Deep sleep may function as a buffer against cognitive decline in older adults with Alzheimer’s disease (AD) pathology by protecting cognitive reserve, new research suggests. Investigators […]
May 11, 2023
Rheumatoid arthritis (RA) is linked to almost a twofold increased risk for Parkinson’s disease (PD), new research shows. Claims data in 55,000 patients with RA and […]
May 10, 2023
LOS ANGELES — Patients with supratentorial intracerebral hemorrhage (ICH) had better outcomes when they were treated with a form of minimally invasive surgery to remove clots […]
May 10, 2023
The majority of antidepressants prescribed for chronic pain lack sufficient evidence of efficacy and safety, results of a large Cochrane review show. “This is a global […]
May 9, 2023
A significant number of epilepsy patients turn to nonmedical cannabis for seizure control, often without their physician’s knowledge, new research shows. “It’s well-accepted that CBD is […]
May 5, 2023
BOSTON — In emergency department stroke consultations, the National Institute of Health Stroke Scale (NIHSS) alone does not appear to be a reliable guide for ordering diagnostic […]
May 5, 2023
In patients with radiologically isolated syndrome (RIS) predictive of multiple sclerosis (MS), teriflunomide reduced the risk of a demyelinating event by more than 60% over a […]
May 5, 2023
Untreated hearing loss increases dementia risk in middle-aged and older adults, new research confirms. A large observational study from the United Kingdom showed a 42% increased […]